Gesynta Pharma
Göran Tornling holds an MD, Ph.D., and an associate professorship in respiratory medicine at the Karolinska Institutet. Göran has more than 20 years of experience in all phases of drug development including leading positions at AstraZeneca, Biolipox, and Orexo. Göran is the author of more than 100 articles and book chapters.
This person is not in any offices
Gesynta Pharma
Developing unique drug candidates aiming to reduce harmful inflammation and increase blood flow in the body’s microvasculature.